With the rising popularity of GLP-1 medications, such as semaglutide and tirzepatide, individuals across Michigan now have access to cutting-edge weight management solutions
These findings indicate that liraglutide, semaglutide, and tirzepatide were each associated with significant improvements in liver enzyme levels over the 36-week treatment period, without evidence of differential effects between agents (Table 6 and Figure 4)
Food and Drug Administration (FDA) narrowly voted in favour of adding several peptides on the federal agencys list of substances deemed safe for pharmacy compounding
It has not been evaluated by the Food and Drug Administration and is not approved for therapeutic, diagnostic, or human application of any kind
While GLP-1 medications offer many benefits, including when taken on an empty stomach the effects vary from person to person
STEP 1 reported greater improvement in cardiometabolic risk factors and in participant-reported physical functioning with semaglutide, and STEP 4 reported reductions in waist circumference of 9.7 cm and systolic blood pressure of 3.9 mm Hg versus placebo over the randomized period